Leading Manufacturer for Blackcurrant Extract Supply to Los Angeles
Leading Manufacturer for Blackcurrant Extract Supply to Los Angeles Detail:
[Latin Name] Ribes nigrum
[Specification] Anthocyanosides≥25.0%
[Appearance] Purple black fine powder
Plant Part Used: Fruit
[Particle size] 80Mesh
[Loss on drying] ≤5.0%
[Heavy Metal] ≤10PPM
[Storage] Store in cool & dry area, keep away from the direct light and heat.
[Shelf life] 24 Months
[Package] Packed in paper-drums and two plastic-bags inside.
[Net weight] 25kgs/drum
[What is Black currant?]
The black currant bush is a 6-foot tall perennial that entered the world somewhere in the regions that include northern Asia and central and northern Europe. Its flowers display five reddish-green to brownish petals. The celebrated black currant fruit is a glossy-skinned berry that carries several seeds laden with marvelous nutritional and curative treasures. An established bush can produce ten pounds of fruit per season
[Benefits]
1. Vision help my eyesight
2. Urinary Tract Health
3. Ageing & Brain Function.
4. Natural Brain Boost
5. Digestion & Fighting Cancer
6. Reducing Erectile Dysfunction
Product detail pictures:
Related Product Guide:
Leading Manufacturer for Blackcurrant Extract Supply to Los Angeles , The product will supply to all over the world, such as: , , ,
BioCer Entwicklungs GmbH, a Bayreuth, Germany-based medical device manufacturer, are pleased to announce the CE approval of HaemoCer(TM), an Absorbable Polysaccharide Hemostat (APH). Introduction of HaemoCer(TM) APH will commence December 2010 in the European Union and other selected international markets.
HaemoCer(TM) is an absorbable, surgical hemostatic technology created via a Polysacharide Ultra-hydrophilic Resorbable Engineering (PURE) process. PURE processing utilizes sophisticated, plant-based polymer crosslinking that creates ultra-hydrophilic, biocompatible, polysaccharide compounds. The PURE technology format of HaemoCer(TM) is a powder; alternate novel product formats are planned for release Q2 2011. A family of customized, single-use application instruments will enhance the delivery of HaemoCer(TM) particles to the wound site for the control of capillary, venous and arteriolar bleeding in both open and minimally invasive surgical procedures. There is no thrombin, collagen, or other human or animal components in HaemoCer(TM) particles.
For more visit https://www.PLMALive.com
Stevia is adding more than just another color to the sweetener market. PLMA’s new science and technology commentator Kantha Shelke looks at the potential impact on food, drinks and store brands.
By from -
By from -